The No Fentanyl on Social Media Act of 2026 directs the Federal Trade Commission, working with the Food and Drug Administration and the Drug Enforcement Administration, to study how minors are able to obtain fentanyl, including counterfeit pressed pills, through social media platforms. Within one year of the bill becoming law, the FTC must deliver a public report to relevant congressional committees examining how drug sellers use these platforms to market and distribute fentanyl to minors, the health and safety risks involved, platform design features that enable such access, and the effectiveness of current industry and law enforcement efforts to combat the problem. The report must also include recommendations for future congressional action and must be developed in consultation with parents, social media companies, law enforcement, medical professionals, addiction treatment providers, and researchers. The FTC may redact certain sensitive law enforcement details before public release. The bill defines social media platforms broadly to cover websites and apps that primarily host user-generated content, while excluding internet service providers, email, and platforms whose content is mainly preselected by the provider rather than user-generated. This legislation does not create new penalties or regulations but instead mandates fact-finding intended to inform future policymaking on protecting minors from online drug trafficking.